Laura Campogiani

Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study

Marco Iannetta, Francesco Buccisano, Daniela Fraboni et al. · Scientific Reports · 2021 · 41 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications

Marco Iannetta, Doriana Landi, Gaia Cola et al. · Frontiers in Immunology · 2022 · 40 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

T-cell responses to SARS-CoV-2 in multiple sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-spike antibody titers

Marco Iannetta, Doriana Landi, Gaia Cola et al. · Multiple Sclerosis and Related Disorders · 2021 · 33 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Neuro-Axonal Damage and Alteration of Blood–Brain Barrier Integrity in COVID-19 Patients

Maria Antonella Zingaropoli, Marco Iannetta, Lorenzo Piermatteo et al. · Cells · 2022 · 32 citations · Full text

Life Sciences, Neurology, Neuroscience +16

Clinical Characteristics and Outcome of Ceftazidime/Avibactam-Resistant <i>Klebsiella pneumoniae</i> Carbapenemase–Producing <i>Klebsiella pneumoniae</i> Infections: A Retrospective, Observational, 2-Center Clinical Study

Alessandra Oliva, Laura Campogiani, Giulia Savelloni et al. · Open Forum Infectious Diseases · 2023 · 22 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17